A Drug-Drug Interaction Study of Digoxin and PA21

Completed · Phase 1

Conditions studied: Drug Interaction Potentiation

In brief

The purpose of this study is to determine if Digoxin is affected by PA21.

Key facts

Study ID

NCT01477411

Run by

Vifor Pharma

People needed

42

Starts

2011-11-01

Expected to finish

2012-01-01

Last updated by the study team

2012-01-18

Who can join

Age: 20 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers
• Written informed consent

You may not qualify if…

• No significant medical conditions
• Pregnancy

Where it is running

• ACRI - Phase 1 — Anaheim, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.